Assignee
LIPOSCIENCE INC
US37 patents
Top patents by PatentIndex Score
US6576471B2Jun 10, 2003
Methods, systems, and computer program products for analyzing and presenting NMR lipoprotein-based risk assessment results
LIPOSCIENCE INC92 citations98
US6518069B1Feb 11, 2003
Methods and computer program products for determining risk of developing type 2 diabetes and other insulin resistance related disorders
LIPOSCIENCE INC81 citations97
US6617167B2Sep 9, 2003
Method of determining presence and concentration of lipoprotein X in blood plasma and serum
LIPOSCIENCE INC61 citations95
US7790465B2Sep 7, 2010
Methods, systems and computer programs for assessing CHD risk using adjusted LDL particle number measurements
LIPOSCIENCE INC29 citations92
US6653140B2Nov 25, 2003
Methods for providing personalized lipoprotein-based risk assessments
LIPOSCIENCE INC23 citations92
US9361429B2Jun 7, 2016
Multi-parameter diabetes risk evaluations
LIPOSCIENCE INC17 citations91
US8013602B2Sep 6, 2011
NMR clinical analyzers and related methods, systems, modules and computer program products for clinical evaluation of biosamples
LIPOSCIENCE INC32 citations90
US9483612B2Nov 1, 2016
CHD risk stratification evaluations for subjects with high levels of large HDL-P
LIPOSCIENCE INC4 citations84
US8386187B2Feb 26, 2013
Lipoprotein insulin resistance indexes and related methods, systems and computer programs for generating same
LIPOSCIENCE INC14 citations84
US7243030B2Jul 10, 2007
Methods, systems and computer programs for deconvolving the spectral contribution of chemical constituents with overlapping signals
LIPOSCIENCE INC54 citations84
US9470771B2Oct 18, 2016
NMR measurements of NMR biomarker GlycA
LIPOSCIENCE INC10 citations83
US10388414B2Aug 20, 2019
Multi-parameter diabetes risk evaluations
LIPOSCIENCE INC6 citations82
US9792410B2Oct 17, 2017
Multi-parameter diabetes risk evaluations
LIPOSCIENCE INC10 citations82
US9541620B2Jan 10, 2017
NMR quantification of TMAO
LIPOSCIENCE INC5 citations82
US10365339B2Jul 30, 2019
NMR analyzers for clinical evaluation of biosamples
LIPOSCIENCE INC5 citations81
US11231429B2Jan 25, 2022
Cardiovascular risk evaluations using a risk parameter that includes an HDL and inflammatory biomarker interaction parameter
LIPOSCIENCE INC2 citations73
US11156621B2Oct 26, 2021
Multi-parameter metabolic vulnerability index evaluations
LIPOSCIENCE INC2 citations73
US11037683B2Jun 15, 2021
Multiple-marker risk parameters predictive of conversion to diabetes
LIPOSCIENCE INC1 citations73
US10504610B2Dec 10, 2019
Methods, systems and computer programs for assessing CHD risk using adjusted HDL article number measurements
LIPOSCIENCE INC2 citations73
US10386355B2Aug 20, 2019
CHD risk stratification evaluations for subjects with high levels of large HDL-P
LIPOSCIENCE INC3 citations73
US9952232B2Apr 24, 2018
Cardiovascular risk evaluations using a risk parameter that includes an HDL and inflammatory biomarker interaction parameter
LIPOSCIENCE INC4 citations73
US9928345B2Mar 27, 2018
Multiple-marker risk parameters predictive of conversion to diabetes
LIPOSCIENCE INC3 citations73
US10852293B2Dec 1, 2020
NMR measurements of NMR biomarker GlycA
LIPOSCIENCE INC2 citations72
US10613044B2Apr 7, 2020
NMR quantification of TMAO
LIPOSCIENCE INC2 citations71
US11156685B2Oct 26, 2021
NMR analyzers for clinical evaluation of biosamples
LIPOSCIENCE INC1 citations70
US9535144B2Jan 3, 2017
NMR quantification of TMAO
LIPOSCIENCE INC3 citations69
US12130295B2Oct 29, 2024
NMR system and methods for multi-parameter metabolic vulnerability index evaluations
LIPOSCIENCE INC0 citations62
US11988679B2May 21, 2024
Cardiovascular risk evaluations using a risk parameter that includes an HDL and inflammatory biomarker interaction parameter
LIPOSCIENCE INC0 citations62
US11990243B2May 21, 2024
Multiple-marker risk parameters predictive of conversion to diabetes
LIPOSCIENCE INC0 citations62
US11942187B2Mar 26, 2024
Methods, systems and computer programs for assessing CHD risk using adjusted HDL particle number measurements
LIPOSCIENCE INC0 citations62
US11703501B2Jul 18, 2023
CHD risk stratification evaluations for subjects with high levels of large HDL-P
LIPOSCIENCE INC0 citations62
US11692995B2Jul 4, 2023
NMR measurements of NMR biomarker GlycA
LIPOSCIENCE INC0 citations62
US9483611B2Nov 1, 2016
Protective HDL particle number evaluations
LIPOSCIENCE INC2 citations62
US11782002B2Oct 10, 2023
NMR quantification of TMAO
LIPOSCIENCE INC0 citations61
US11710568B2Jul 25, 2023
Multi-parameter diabetes risk evaluations
LIPOSCIENCE INC0 citations61
US11467171B2Oct 11, 2022
Methods and systems to detect and quantify the amount of LP-X and other abnormal lipoproteins in a biosample using NMR spectroscopy
LIPOSCIENCE INC0 citations50
US11124837B2Sep 21, 2021
Methods and systems for predicting colorectal cancer incidence and mortality
LIPOSCIENCE INC0 citations50